Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Antiviral Research|June 23, 2022
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategiesMarwah Karim, Sirle Saul, Luca Ghita, et al.
Nature Communications|November 6, 2021
Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferretsRobert M Cox, Josef D Wolf, Carolin M Lieber, et al.
Journal of Virology|November 12, 2025
Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functionsKrithika Muthuraman, Matthew Jackman, Yu Liang, et al.
Npj Viruses|November 18, 2024
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsMichael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
NPJ Vaccines|November 17, 2024
A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigsBrian D Carey, Shuiqing Yu, Jillian Geiger, et al.
Cell Reports. Medicine|March 2, 2021
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamstersMichael S Piepenbrink, Jun-Gyu Park, Fatai S Oladunni, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsMichael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2025
Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmissionCheng Chih Hsu, Michelle Chamblee, Chengjin Ye, et al.
Pageof 12